Cargando…
Tumor lineage-specific immune response in brain metastatic disease: opportunities for targeted immunotherapy regimen?
Metastases in the brain are the most severe and devastating complication of cancer. The incidence of brain metastasis is increasing. Therefore, the need of finding specific druggable targets for brain metastasis is demanding. The aim of this study was to compare the brain (immune) response to brain...
Autores principales: | Najjary, Shiva, Kros, Johan M., de Koning, Willem, Vadgama, Disha, Lila, Karishma, Wolf, Janina, Mustafa, Dana A. M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10105417/ https://www.ncbi.nlm.nih.gov/pubmed/37061716 http://dx.doi.org/10.1186/s40478-023-01542-9 |
Ejemplares similares
-
Immunotherapy regimens for metastatic colorectal carcinomas
por: Bashir, Babar, et al.
Publicado: (2017) -
Metabolic alterations due to IDH1 mutation in glioma: opening for therapeutic opportunities?
por: N Mustafa, Dana A, et al.
Publicado: (2014) -
Cerebral Metastasis of Common Cancers
por: Kros, Johan M., et al.
Publicado: (2020) -
Efficacy of novel immunotherapy regimens in patients with metastatic melanoma with germline CDKN2A mutations
por: Helgadottir, Hildur, et al.
Publicado: (2020) -
Ecological opportunity and the adaptive diversification of lineages
por: Wellborn, Gary A, et al.
Publicado: (2015)